OVRAL 21 TAB DIN 00034207
Health Canada record
| Active ingredient(s) | NORGESTREL (NORGESTREL) .25 MG; ETHINYL ESTRADIOL .05 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03AA06 NORGESTREL AND ESTROGEN |
| Original market date | 31-Dec-1968 |
| Current status date | 14-Aug-1997 |
| Source | Health Canada DPD |
Establishment licence of the holder
Wyeth Pharmaceutical Division of Wyeth Holdings LLC — licence , not currently licensed, last inspection rating C (2025-12-04).
No Canadian shortage report is currently matched to this DIN.
Request a quote for OVRAL 21 TAB